GGrantIndex
← Search

Development Funds

$2,077,511P30FY2023CANIH

Fred Hutchinson Cancer Center, Seattle WA

Investigators

Linked publications, trials & patents

Trial NCT06995898Trial NCT06682039Trial NCT06484595Trial NCT06193070Trial NCT05947500Trial NCT05930496Trial NCT05183828Trial NCT04902144Trial NCT04751383Trial NCT04682301Trial NCT04667481Trial NCT04660331Trial NCT04539366Trial NCT04505553Trial NCT04502524Trial NCT04500548Trial NCT04496219Trial NCT04489719Trial NCT04472338Trial NCT04466475Trial NCT04447313Trial NCT04444232Trial NCT04442581Trial NCT04431479Trial NCT04410900Trial NCT04387227Trial NCT04384692Trial NCT04383743Trial NCT04375631Trial NCT04372927Trial NCT04370301Trial NCT04359784Trial NCT04336943Trial NCT04329065Trial NCT04282187Trial NCT04260776Trial NCT04257578Trial NCT04254133Trial NCT04231877Trial NCT04220229Trial NCT04211766Trial NCT04208724Trial NCT04205409Trial NCT04200482Trial NCT04198922Trial NCT04196010Trial NCT04195945Trial NCT04195633Trial NCT04194918Trial NCT04188912Trial NCT04175431Trial NCT04156828Trial NCT04155840Trial NCT04151940Trial NCT04120246Trial NCT04111497Trial NCT04083183Trial NCT04083170Trial NCT04081779Trial NCT04081298Trial NCT04062955Trial NCT04060849Trial NCT03999515Trial NCT03991884Trial NCT03986502Trial NCT03980769Trial NCT03970096Trial NCT03907527Trial NCT03891784Trial NCT03864419Trial NCT03807063Trial NCT03806192Trial NCT03781778Trial NCT03779867Trial NCT03779854Trial NCT03778021Trial NCT03776864Trial NCT03749460Trial NCT03747484Trial NCT03737955Trial NCT03723863Trial NCT03718338Trial NCT03672981Trial NCT03670966Trial NCT03670069Trial NCT03660930Trial NCT03649841Trial NCT03641287Trial NCT03606486Trial NCT03602898Trial NCT03600038Trial NCT03585231Trial NCT03574012Trial NCT03570476Trial NCT03531918Trial NCT03525106Trial NCT03523195Trial NCT03522584Trial NCT03518242Trial NCT03516812

Abstract

PROJECT SUMMARY: DEVELOPMENTAL FUNDS Developmental funds were used in the last cycle for recruiting new investigators, supporting developmental projects, creating new shared resources, and helping fund several key staff investigators. Several outstanding investigators who received recruitment funds during the project period would not have come to Seattle without the extra support that was offered through the availability of CCSG New Investigator Awards, distributed to faculty from Fred Hutch (FH), University of Washington (UW), and Seattle Children’s (SC). The availability of CCSG Pilot Award funding provides investigators a very tangible benefit of Cancer Consortium membership and has stimulated new initiatives and collaborations that would otherwise not have occurred, particularly in transdisciplinary science, cancer health disparities, and catchment area health. Funds to catalyze new Shared Resource development have afforded Consortium members access to technologies and expertise that would otherwise not be sustainable in an individual laboratory or even on an institutional basis. Finally, developmental funds help support staff investigators focused on enhancing our community outreach and engagement efforts. During the last grant period, Developmental Funds supported the recruitment of 33 productive Consortium faculty members in areas of strategic growth and funded 45 Pilot Award projects. Together, these faculty members and pilot projects gave rise to a total of 439 publications and over $28M in new follow-on funding. In the last cycle, Developmental Funds were instrumental in the formation of the Hutch Data Commonwealth and supported two Special Populations Staff Investigators, both of whom continue to lead efforts to reduce disparities in underserved populations and one of whom has become the new Director of our Office of Community Outreach & Engagement. In this application, we are requesting funds to support future Pilot and New Investigator Awards, two new Special Populations Staff Investigators, and a Preclinical Models Shared Resource.

View original record on NIH RePORTER →